102 related articles for article (PubMed ID: 8306810)
1. Increased resistance of encapsulated Bacteroides fragilis to clindamycin.
Brook I; Gillmore JD
Chemotherapy; 1994; 40(1):16-20. PubMed ID: 8306810
[TBL] [Abstract][Full Text] [Related]
2. Bacteroides fragilis resistance to clindamycin in vitro.
Sosa A; Tally FP; Jacobus NV; Gorbach SL
Antimicrob Agents Chemother; 1982 Nov; 22(5):771-4. PubMed ID: 7181487
[TBL] [Abstract][Full Text] [Related]
3. Susceptibility of anaerobic bacteria to five antimicrobial agents and demonstration of resistance of Bacteroides fragilis to clindamycin.
Sofianou D; Douboyas J; Papapanagiotou J; Paradelis AG
Methods Find Exp Clin Pharmacol; 1982; 4(3):173-7. PubMed ID: 7121128
[TBL] [Abstract][Full Text] [Related]
4. High prevalence of resistance to clindamycin in Bacteroides fragilis group isolates.
Oteo J; Aracil B; Alós JI; Gómez-Garcés JL
J Antimicrob Chemother; 2000 May; 45(5):691-3. PubMed ID: 10797095
[TBL] [Abstract][Full Text] [Related]
5. Characterization of bactericidal activity of clindamycin against Bacteroides fragilis via kill curve methods.
Klepser ME; Banevicius MA; Quintiliani R; Nightingale CH
Antimicrob Agents Chemother; 1996 Aug; 40(8):1941-4. PubMed ID: 8843310
[TBL] [Abstract][Full Text] [Related]
6. Susceptibility trends of Bacteroides fragilis group isolates from Buenos Aires, Argentina.
Fernández Canigia L; Castello L; Di Martino A; Greco G; Legaria MC; Litterio M; Predari SC; Rollet R; Rossetti A; Carloni G; Sarchi MI; Bianchini H
Rev Argent Microbiol; 2007; 39(3):156-60. PubMed ID: 17987852
[TBL] [Abstract][Full Text] [Related]
7. Modified broth-disk surveillance of clindamycin-resistant Bacteroides fragilis group.
Zar FA
Antimicrob Agents Chemother; 1983 Jun; 23(6):947-9. PubMed ID: 6614896
[TBL] [Abstract][Full Text] [Related]
8. Genetic analysis of clindamycin resistance in Bacteroides species.
Guiney DG; Hasegawa P; Stalker D; Davis CE
J Infect Dis; 1983 Mar; 147(3):551-8. PubMed ID: 6833799
[TBL] [Abstract][Full Text] [Related]
9. Bactericidal activity of ceftizoxime, cefotetan, and clindamycin against cefoxitin-resistant strains of the Bacteroides fragilis group.
Aldridge KE; Stratton CW
J Antimicrob Chemother; 1991 Nov; 28(5):701-5. PubMed ID: 1778873
[TBL] [Abstract][Full Text] [Related]
10. Six-year retrospective survey of the resistance of Bacteroides fragilis group species to clindamycin and cefoxitin.
Wexler HM; Harris B; Carter WT; Finegold SM
Diagn Microbiol Infect Dis; 1986 Mar; 4(3):247-53. PubMed ID: 3956142
[TBL] [Abstract][Full Text] [Related]
11. Clindamycin resistance in anaerobic bacteria.
Tally FP; Cuchural GJ; Bieluch VM; Jacobus NV; Malamy MH
Scand J Infect Dis Suppl; 1984; 43():34-43. PubMed ID: 6598519
[TBL] [Abstract][Full Text] [Related]
12. Clindamycin resistance transfer in Bacteroides fragilis.
Teng LJ; Liaw SJ; Luh KT; Ho SW
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1994 Nov; 27(4):186-95. PubMed ID: 9747348
[TBL] [Abstract][Full Text] [Related]
13. Disc diffusion method to screen for high-level resistance to clindamycin and erythromycin in the Bacteroides fragilis group.
Callihan DR; Nolte FS
Diagn Microbiol Infect Dis; 1985 Mar; 3(2):131-7. PubMed ID: 3979019
[TBL] [Abstract][Full Text] [Related]
14. [Activity of seven antimicrobial agents against "Bacteroides fragilis" (author's transl)].
Tytgat F
Ann Microbiol (Paris); 1980; 131(1):39-44. PubMed ID: 6899739
[TBL] [Abstract][Full Text] [Related]
15. Bacteroides fragilis group: trends in resistance.
Fille M; Mango M; Lechner M; Schaumann R
Curr Microbiol; 2006 Feb; 52(2):153-7. PubMed ID: 16450067
[TBL] [Abstract][Full Text] [Related]
16. The clinical significance of clindamycin-resistant Bacteroides fragilis.
Yee MH; Guiney DG; Hasegawa P; Davis CE
JAMA; 1982 Oct; 248(15):1860-1. PubMed ID: 7120605
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology of clindamycin resistance in the Bacteroides fragilis group.
Reig M; Campello MG; Baquero F
J Antimicrob Chemother; 1984 Dec; 14(6):595-603. PubMed ID: 6520060
[TBL] [Abstract][Full Text] [Related]
18. Relative antibacterial efficacy of clindamycin and metronidazole against Bacteroides fragilis in vitro and in experimentally infected mice.
Dijkmans BA; Vaishnav J; Mattie H
Chemotherapy; 1985; 31(4):297-303. PubMed ID: 4028873
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial susceptibility patterns and resistance transferability among Bacteroides fragilis group isolates from patients with appendicitis in Bali, Indonesia.
Suata K; Watanabe K; Ueno K; Homma M
Clin Infect Dis; 1993 Apr; 16(4):561-6. PubMed ID: 8513066
[TBL] [Abstract][Full Text] [Related]
20. Trends in antimicrobial resistance among clinical isolates of the Bacteroides fragilis group from 1992 to 1997 in Montreal, Canada.
Labbé AC; Bourgault AM; Vincelette J; Turgeon PL; Lamothe F
Antimicrob Agents Chemother; 1999 Oct; 43(10):2517-9. PubMed ID: 10508035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
